These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27721225)

  • 1. A Challenging Interaction of Chronic Kidney Disease With Other Metabolic Disorders: Paradoxes in Cardiometabolic Risk Factors.
    Panahi MH; Hadaegh F; Yavari P; Kazempour-Ardebili S; Mehrabi Y; Azizi F; Khalili D
    Iran J Kidney Dis; 2016 Sep; 10(5):274-281. PubMed ID: 27721225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and chronic kidney disease.
    Belarbia A; Nouira S; Sahtout W; Guedri Y; Achour A
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):931-40. PubMed ID: 26354564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort.
    Cao X; Zhou J; Yuan H; Wu L; Chen Z
    BMC Nephrol; 2015 Jun; 16():85. PubMed ID: 26084279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks.
    Onat A; Yazici M; Can G; Kaya Z; Bulur S; Hergenç G
    Am J Hypertens; 2008 Aug; 21(8):890-5. PubMed ID: 18551102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study.
    Viazzi F; Garneri D; Leoncini G; Gonnella A; Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Agabiti Rosei E; Deferrari G; Pontremoli R
    Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):921-7. PubMed ID: 24675005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
    Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and chronic kidney disease in high-risk Italian hypertensive patients: the I-DEMAND study.
    Leoncini G; Viazzi F; Agabiti Rosei E; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Deferrari G; Pontremoli R
    J Nephrol; 2012; 25(1):63-74. PubMed ID: 21534241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation in a Structured Weight Loss Program and All-Cause Mortality and Cardiovascular Morbidity in Obese Patients With Chronic Kidney Disease.
    MacLaughlin HL; Hall WL; Condry J; Sanders TA; Macdougall IC
    J Ren Nutr; 2015 Nov; 25(6):472-9. PubMed ID: 26143293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis.
    Ponte B; Pruijm M; Marques-Vidal P; Martin PY; Burnier M; Paccaud F; Waeber G; Vollenweider P; Bochud M
    Nephrol Dial Transplant; 2013 Sep; 28(9):2329-39. PubMed ID: 23825103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study.
    Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Can G
    Atherosclerosis; 2007 Mar; 191(1):182-90. PubMed ID: 16678831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects.
    Gatti A; Morini E; De Cosmo S; Maiani F; Mandosi E; Fallarino M; Morano S; Trischitta V
    Obesity (Silver Spring); 2008 Apr; 16(4):899-901. PubMed ID: 18239564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney measures with diabetes and hypertension on cardiovascular disease: the Atherosclerosis Risk in Communities Study.
    Alexander N; Matsushita K; Sang Y; Ballew S; Mahmoodi BK; Astor BC; Coresh J
    Am J Nephrol; 2015; 41(4-5):409-17. PubMed ID: 26139323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of chronic kidney disease and its contributing risk factors in southern Iran: a cross-sectional adult population-based study.
    Khajehdehi P; Malekmakan L; Pakfetrat M; Roozbeh J; Sayadi M
    Iran J Kidney Dis; 2014 Mar; 8(2):109-15. PubMed ID: 24685733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome component combinations and chronic kidney disease: the severance cohort study.
    Cho JA; Lee SJ; Reid EA; Jee SH
    Maturitas; 2013 May; 75(1):74-80. PubMed ID: 23489551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in Associations Among Obesity, Metabolic Abnormalities, and Chronic Kidney Disease in Japanese Men and Women.
    Sakurai M; Kobayashi J; Takeda Y; Nagasawa SY; Yamakawa J; Moriya J; Mabuchi H; Nakagawa H
    J Epidemiol; 2016 Aug; 26(8):440-6. PubMed ID: 27087606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of combined target-organ damage in patients with essential hypertension.
    Carpinella G; Pagano G; Buono F; Petitto M; Guarino G; Orefice G; Rengo G; Trimarco B; Morisco C
    Am J Hypertens; 2015 Jan; 28(1):127-34. PubMed ID: 24936579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors.
    Carnethon MR; Gidding SS; Nehgme R; Sidney S; Jacobs DR; Liu K
    JAMA; 2003 Dec; 290(23):3092-100. PubMed ID: 14679272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition].
    Onat A; Hergenç G; Can G
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):29-34. PubMed ID: 17347072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
    Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
    J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.